Search Within

Alison Michele Schram

  1. "Gastrointestinal Oncology Service"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (13)
  3. Research Letter (1)
Groups
  1. Department of Medicine (28)
  2. Early Drug Development Service (28)
  3. Gastrointestinal Oncology Service (28)
  4. Gynecologic Medicine Service (28)
  5. Solid Tumor Oncology Division (28)
  6. Thoracic Oncology (27)

More Groups

People
  1. Alexander Drilon (25)
  2. David Hyman (15)
  3. Michael Berger (12)
  4. James Harding (11)
  5. Eileen O'Reilly (9)
  6. Bob Li (7)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (5)
  5. 2020 (4)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Annals of Oncology (4)
  3. Cancer Research (3)
  4. Nature Medicine (2)
  5. Cancer (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (5)
  3. Nature Publishing Group (4)
  4. Oxford University Press (4)
  5. Elsevier Inc. (2)
  6. American Medical Association (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of zenocutuzumab in NRG1 fusion-positive cancer
    Journal Article

    Schram, A. M.; Goto, K.; Kim, D. W.; Macarulla, T.; Hollebecque, A.; O'Reilly, E. M.; Ou, S. H. I.; Rodon, J.; Rha, S. Y.; Nishino, K.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion positive (NRG1+) pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Schram, A.; Macarulla, T.; Cleary, J.; Neuzillet, C.; Arnold, D.; Reiss, K. A.; Bekaii-Saab, T.; Rodon, J.; Goto, K.; Rha, S. Y.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers
    Meeting Abstract

    Schram, A. M.; Goto, K.; Kim, D. W.; Martin-Romano, P.; Ou, S. H. I.; O'Kane, G. M.; O'Reilly, E. M.; Umemoto, K.; Duruisseaux, M.; Neuzillet, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
    Journal Article

    Murciano-Goroff, Y. R.; Schram, A. M.; Rosen, E. Y.; Won, H.; Gong, Y.; Noronha, A. M.; Janjigian, Y. Y.; Stadler, Z. K.; Chang, J. C.; Yang, S. R.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of extracellular signal-regulated kinase inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Canestraro, J.; Haggag-Lindgren, D.; Harding, J. J.; Diamond, E. L.; Drilon, A.; Li, B. T.; Iyer, G.; Schram, A. M.; Abramson, D. H.
    Ophthalmology Retina (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; O'Kane, G. M.; Goto, K.; Kim, D. W.; Neuzillet, C.; Martin-Romano, P.; Duruisseaux, M.; Nagasaka, M.; Rodon, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies
    Meeting Abstract

    Murciano-Goroff, Y. R.; Schram, A. M.; Rosen, E.; Janjigian, Y. Y.; Berger, M. F.; Donoghue, M.; Bandlamudi, C.; Drilon, A. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save